Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kamada Ltd | KMDA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.12 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.12 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.08 - 6.5291 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 5.12 | USD |
Kamada Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 294.27M | 57.47M | - | 142.52M | 8.28M | 0.14 | 35.53 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kamada News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KMDA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.36 | 5.37 | 5.10 | 5.23 | 18,572 | -0.24 | -4.48% |
| 1 Month | 5.83 | 5.95 | 5.10 | 5.49 | 16,375 | -0.71 | -12.18% |
| 3 Months | 5.71 | 6.5291 | 5.10 | 5.84 | 20,958 | -0.59 | -10.33% |
| 6 Months | 4.75 | 6.5291 | 4.08 | 5.69 | 44,987 | 0.37 | 7.79% |
| 1 Year | 4.61 | 6.5291 | 4.08 | 5.49 | 38,492 | 0.51 | 11.06% |
| 3 Years | 6.32 | 6.96 | 3.721 | 5.44 | 41,094 | -1.20 | -18.99% |
| 5 Years | 6.60 | 13.33 | 3.721 | 7.31 | 87,272 | -1.48 | -22.42% |
Kamada Description
| Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics. |
